Package 0406-8020-03

{"route": ["SUBLINGUAL"], "spl_id": "bd7bf416-c9b0-42fb-9593-077053c1cdd2", "openfda": {"upc": ["0304068005039", "0304068020032"], "unii": ["5Q187997EE", "56W8MW3EN1"], "rxcui": ["351266", "351267"], "spl_set_id": ["62abde41-46cb-4e90-a798-23d6531bf9aa"], "manufacturer_name": ["SpecGx LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE, PLASTIC (0406-8020-03)", "package_ndc": "0406-8020-03", "marketing_start_date": "20171213"}], "brand_name": "Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate", "product_id": "0406-8020_bd7bf416-c9b0-42fb-9593-077053c1cdd2", "dosage_form": "TABLET", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]", "Partial Opioid Agonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "0406-8020", "dea_schedule": "CIII", "generic_name": "Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate", "labeler_name": "SpecGx LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate", "active_ingredients": [{"name": "BUPRENORPHINE HYDROCHLORIDE", "strength": "8 mg/1"}, {"name": "NALOXONE HYDROCHLORIDE DIHYDRATE", "strength": "2 mg/1"}], "application_number": "ANDA207000", "marketing_category": "ANDA", "marketing_start_date": "20171213", "listing_expiration_date": "20261231"}